USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lessened its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 51.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,298 shares of the company’s stock after selling 9,724 shares during the quarter. Jane Street Group LLC’s holdings in USANA Health Sciences were worth $353,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. State Street Corp boosted its holdings in USANA Health Sciences by 0.6% in the third quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after acquiring an additional 2,782 shares in the last quarter. Safe Harbor Fiduciary LLC purchased a new position in shares of USANA Health Sciences in the third quarter worth about $30,000. Centiva Capital LP purchased a new position in shares of USANA Health Sciences in the third quarter worth about $213,000. Martingale Asset Management L P raised its stake in shares of USANA Health Sciences by 2.1% in the third quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after purchasing an additional 340 shares during the last quarter. Finally, Pacer Advisors Inc. raised its stake in shares of USANA Health Sciences by 16.5% in the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after purchasing an additional 76,904 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 28th. DA Davidson raised their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research note on Thursday, January 2nd.

Insider Activity at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

USANA Health Sciences Trading Down 1.2 %

Shares of USNA stock opened at $34.90 on Thursday. The stock has a 50 day moving average of $37.73 and a 200 day moving average of $39.33. The stock has a market cap of $665.19 million, a P/E ratio of 12.33, a P/E/G ratio of 1.25 and a beta of 0.89. USANA Health Sciences, Inc. has a twelve month low of $31.44 and a twelve month high of $52.75.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period last year, the business earned $0.59 earnings per share. On average, research analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.